Lassa virus infection
Material: | Antibody demonstration: 2 ml serum, 0,5 ml CSF |
Methods: | Ligandenassays → Immunfluoreszenzassay (IFA) | Criteria for evaluation | < 1:20 titer | Mandatory reporting | ja The laboratory has to report any direct and indirect demonstration to the responsible health department, stating the patient’s name. The treating physician has to report suspicion of virus-induced hemorrhagic fever as well as illness and death. |
Please note | Reported cases in West Africa in the past few years. Infection by ingestion of food contaminated with urine of infected animals (rats). Incubation period is between 8 and 14 days. The disease begins gradually with fever, headaches and a saw throat, retrosternal pains, arthralgia and proteinuria.
The Lassa virus belongs to risk class 4 and therefore must not be handled by our laboratory. On suspicion, please send the samples directly to the Bernhard-Nocht-Institute for tropical medicine in Hamburg (prior telephone contact with the BNITM required!)
Further information can be found here: www.rki.de |
External services | ja |
Please also refer to: | Hemorrhagic fever, viral |
More Results for the letter L
- Lipometabolism diagnostics (LIPID)
- fat metabolism diagnostics
- Lipoprotein (a) = Lp (a) (LPA)
- Listeriosis (KLIST, LISMON)
- Listeria monocytogenes
- Lithium (LI)
- LKM autoantibodies (LKM)
- autoantibodies to liver and kidney microsomes
- LMA autoantibodies (LMA)
- Liver membrane antigen autoantibodies
- Lorazepam (LORA)
- Lormetazepam (LORM)
- LSD (LSDU)
- Lysergic acid diethylamide
- Lupus coagulant activity (LUPAK)
- Lymphocyte differentiation (LYMPD, LYMPDG, TREG, TAKT)
- Immune status
- Lysozyme (LYSOZ)